As the pharmaceutical, nutraceutical, and herbal wellness industries continue to witness rapid growth, the need for dependable and quality driven supply partners has become more crucial than ever. In this evolving business landscape, Star Bio Pharma has emerged as a growing force in the domain of B2B pharmaceutical
“Poised for Takeoff: MedTech in India” report launched at the national policy platform attended by over 450 delegates and 70+ eminent speakers from government, industry, research institutions, and healthcare ecosystems The 3rd Edition of MedTech Policy Mahotsav 2026, organized by Global MedTech Advocacy & Advisory Forum
Approval marks Venus Remedies’ entry into Argentina for Ceftriaxone, taking total global MAs for the antibiotic to 39 Argentina is the 4th-largest pharmaceutical market in Latin America, valued at approximately US$7.3 billion in 2023 Approval strengthens Venus Remedies’ growing international anti infective portfolio amid rising burden of infectious
The approvals strengthen India’s position as a reliable supplier of advanced pharmaceuticals across ASEAN markets where Venus Remedies already exports more than 374 products. Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the 10 leading fixed-dosage injectable manufacturers in the world, has secured new marketing authorizations
The evolving biosimilar regulations in the United States are poised to create new growth opportunities for Indian pharmaceutical companies, with experts predicting a significant uptick in exports and partnerships in the biopharma segment. The U.S. Food and Drug Administration’s (FDA) streamlined approval pathway for biosimilars, along
In a move aimed at supporting India’s fast-growing medical device industry, the Government of India has announced the alignment of packaging and labeling rules for medical devices, easing compliance requirements and promoting regulatory clarity for manufacturers. The Department of Consumer Affairs, in coordination with the Central
The Central Drugs Standard Control Organisation (CDSCO) has directed all State and Union Territory drug controllers to submit a comprehensive list of cough syrup manufacturers operating within their jurisdictions. The move comes as part of a nationwide joint audit initiative aimed at strengthening quality assurance
The Indian Medical Association (IMA) has strongly condemned the arrest of a doctor in connection with the recent deaths allegedly linked to contaminated cough syrup in Madhya Pradesh, calling the move “unjustified” and “deeply demoralizing for the medical fraternity.” In a statement issued on Monday, the
Indian manufacturers urge for stricter scrutiny, citing data privacy, quality, and national security concerns India’s domestic medical technology (MedTech) manufacturers have raised serious alarms regarding the increasing penetration of Chinese medical devices in the Indian healthcare ecosystem, flagging major concerns about national security, data privacy, and
JATIN MAHAJAN Secretary, Association of Diagnostics Manufacturers of India (ADMI) The perception that imported products are superior to Indian-made ones is deeply ingrained in the Indian psyche, rooted more in legacy and sentiment than in objective reality. However, this perception is increasingly outdated. India has made significant
